NeoGenomics Reports 40% Revenue Growth to $107 Million in the Fourth Quarter
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
NeoGenomics (NEO) Reports In-Line Q4 EPS, Offers Guidance
February 27, 2020 7:35 AM ESTNeoGenomics (NASDAQ: NEO) reported Q4 EPS of $0.06, in-line with the analyst estimate of $0.06. Revenue for the quarter came in at $106.9 million versus the consensus estimate of $104.24 million.
GUIDANCE:
NeoGenomics sees FY2020 revenue of $464-474 million, versus the consensus of $448.3... More
